Fake Knee Surgery as Good as Real Procedure, Study Finds; Result Likely to Fuel Debate Over Common Orthopedic Operation

Fake Knee Surgery as Good as Real Procedure, Study Finds

Result Likely to Fuel Debate Over Common Orthopedic Operation

JOSEPH WALKER

Dec. 25, 2013 5:10 p.m. ET

NA-BZ418_KNEES_NS_20131225164807

A fake surgical procedure is just as good as real surgery at reducing pain and other symptoms in some patients suffering from torn knee cartilage, according to a new study that is likely to fuel debate over one of the most common orthopedic operations.As many as 700,000 people in the U.S. undergo knee surgery each year to treat tears in a crescent-shaped piece of cartilage known as the meniscus, which acts as a shock absorber between the upper and lower portions of the knee joints. The tears create loose pieces of cartilage that doctors have long thought interfere with motion of the joints, causing pain and stiffness.

But researchers in Finland who studied two sets of patients—one that received the surgery, and another that was led to believe that it had—observed no significant differences in improvement between the groups after one year.

Surgery did provide a slight advantage in certain areas early on, including a decrease in pain felt after exercising and in some quality-of-life measures, but the differences disappeared by the end of the 12 months, the researchers said in a paper published Wednesday in the New England Journal of Medicine.

The patients agreed to participate in the study prior to the procedure and were informed they would either receive the surgery or not.

“The implications are fairly profound,” said Jeffrey Katz, a professor of medicine at Brigham and Women’s Hospital in Boston who wasn’t involved in the Finnish study. “There may be some relatively small advantages to meniscal surgery, but they’re short-lived.”

The study is likely to stir controversy over the minimally invasive procedure, known as partial meniscectomy, which can cost between $3,000 and $6,000. The study’s authors estimated that it accounts for $4 billion in annual medical costs in the U.S.

The study’s relatively small sample size of 146 patients, however, makes it difficult to draw definitive conclusions about the procedure’s effectiveness, some physicians said.

“It’s hard to step back and say arthroscopy is overdone,” said Nicholas Giori, an associate professor of orthopedic surgery at Stanford University.

 

Teppo L.N. Järvinen, one of the study’s authors, said he was uncertain whether the research paper would change clinical practice. A previous study showed that physical therapy was just as effective as surgery for patients with both a meniscal tear and osteoarthritis, but many physicians have continued to recommend the procedures anyway, he said. “Doctors have a bad tendency to confuse what they believe with what they know,” said Dr. Järvinen, an orthopedic resident and adjunct professor at Helsinki University Central Hospital.

Meniscectomy is performed by inserting thin surgical instruments, including one called an arthroscope that is equipped with a video camera, through incisions in the knee. In a partial meniscectomy, the procedure evaluated in this study, surgeons trim and removes torn pieces rather than the entire meniscus so that they don’t interfere with the flexing of the knee joint.

Patients in the Finnish study were between 35 and 65 years old and suffered from meniscus tears that appeared gradually over time, rather than after a specific traumatic event like a sports injury. They underwent arthroscopy to confirm the tears, but for patients in the control group, doctors didn’t remove the cartilage. Patients received either local anesthesia or general anesthesia that put them to sleep for the duration of the procedure. For control patients who were awake, physicians simulated the procedure by pressing instruments firmly against the outer portion of the knee and kept patients in the operating room for the length of time it would take to complete the surgery.

Similar to the practice of giving some patients sugar pills or placebos in drug studies, simulated surgery is among the most rigorous ways to evaluate the effectiveness of surgical procedures. Medical researchers hope to control for the psychological benefit that patients receive from knowing they have been treated, which can skew study results.

Simulated surgery, which also is used in some medical-device studies, is less common than the use of drug placebos, in part because making incisions into the skin carries risks, such as infection or bleeding. Roughly 150 clinical trials begun this year included a sham procedure, compared with about 2,500 studies that used a drug placebo, according to a search of a clinical trials database run by the National Institutes of Health.

The Finnish researchers excluded many potential patients from entering the study, including those with additional injuries and those who had previously undergone knee operations, in an effort to study only those who were most likely to benefit from the surgery

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment